“…Inflammation occurring in many neurodegenerative diseases, such as multiple sclerosis and Alzheimer's disease, leads to changes in the cellular environment that will favor the activation of oligodendrocyte TRPA1. Endogenous substances that increase TRPA1 expression and activity include reactive oxygen and nitrogen species (Kozai et al, 2014 ; Sullivan et al, 2015 ), hypoxia and hyperoxia (Takahashi et al, 2011 ), and cytokines such as interferon gamma, interleukin 1 beta and tumor necrosis factor‐alpha (Lowin et al, 2015 ). Environmental irritants that can cause demyelination or oligodendrocyte apoptosis (Birgbauer et al, 2004 ; Brambrink et al, 2012 ; Davies et al, 2000 ; Shi et al, 2011 , 2015 ; Tian et al, 2020 ), have also been shown to activate TRPA1, including acrolein (Leishman et al, 2017 ; Park et al, 2015 ), toluene (Taylor‐Clark et al, 2009 ), lysophosphatidylcholine (Tian et al, 2020 ) and isoflurane (Ton et al, 2017 ).…”